Baixar PDF

Outros usuários também visualizaram estes artigos

Diagnosis and treatment of chronic lymphocytic leukemia: 2025 recommendations of the Brazilian Group of Chronic Lymphocytic Leukemia of the Brazilian Association of Hematology and Hemotherapy (ABHH) Carlos Sérgio Chiattone; Fernanda de Morais Marques; Valeria Buccheri; Mihoko Yamamoto; Sergio Costa Fortier; Maura Rosane Valerio Ikoma-Colturato; Nelson Hamerschlak; Vera Lucia de Piratininga Figueiredo; Talita Maira Bueno da Silveira; Abel Costa; Dani Laks; Rony Schaffel; Wolney Gois Barreto; Adriana Scheliga; Pedro Amoedo Fernandes; Samir Kanaan Nabhan; Rafael Dezen Gaiolla; Matheus Vescovi Gonçalves; Danielle Leão Cordeiro de Farias; Glaciano Ribeiro; Marcelo Pitombeira de Lacerda; Celso Arrais-Rodrigues;
Hematol Transfus Cell Ther. 2025;47:
UNEXPECTED SPONTANEOUS REGRESSION IN CLL AFTER LETROZOLE TREATMENT: COINCIDENCE OR CONNECTION? Ennur Ramadan; Mesut Seker; Guven Cetin;
Hematol Transfus Cell Ther. 2025;47 Supl 2:
Subcutaneous low-dose azacitidine as maintenance therapy following hematopoietic stem cell transplantation for acute myeloid leukemia and high-risk myelodysplastic syndrome¿A propensity score matched analysis André Dias Américo; Cinthya Correa Silva; Mariana Nassif Kerbauy; Leonardo Javier Arcuri; Andressa Alice Feitosa Ribeiro; Nelson Hamerschlak; Fábio Pires Souza Santos;
Hematol Transfus Cell Ther. 2024;46 Supl 6:S427-30